A decrease in CD19+ cells in the PAD group as compared to the HC could be because, in the HC, CD19+ B cells increased following two doses of the vaccine, whereas in the PAD group, there might be an impaired response to the vaccine (Figure 13). Here, CD19 is linked to peripheral arterial disease.